160 related articles for article (PubMed ID: 11736943)
1. Rituximab, a chimaeric anti-CD20 monoclonal antibody, in the treatment of hairy cell leukaemia.
Hagberg H; Lundholm L
Br J Haematol; 2001 Dec; 115(3):609-11. PubMed ID: 11736943
[TBL] [Abstract][Full Text] [Related]
2. Chimeric monoclonal anti-CD20 antibody (rituximab)--an effective treatment for a patient with relapsing hairy cell leukaemia.
Hagberg H
Med Oncol; 1999 Sep; 16(3):221-2. PubMed ID: 10523804
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow remission of hairy cell leukaemia induced by rituximab (anti-CD20 monoclonal antibody) in a patient refractory to cladribine.
Hoffman M; Auerbach L
Br J Haematol; 2000 Jun; 109(4):900-1. PubMed ID: 10970137
[No Abstract] [Full Text] [Related]
4. Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report.
Buckstein R; Patel H; Chesney A; Reis M; Imrie K
Hematology; 2006 Aug; 11(4):267-70. PubMed ID: 17178666
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
Lauria F; Lenoci M; Annino L; Raspadori D; Marotta G; Bocchia M; Forconi F; Gentili S; La Manda M; Marconcini S; Tozzi M; Baldini L; Zinzani PL; Foà R
Haematologica; 2001 Oct; 86(10):1046-50. PubMed ID: 11602410
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of rituximab in hairy cell leukemia].
Malfuson JV; Doghmi K; Fagot T; Souleau B; De Revel T; Nedellec G
Presse Med; 2006 May; 35(5 Pt 1):801-2. PubMed ID: 16710151
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of hairy cell leukemia variant with rituximab.
Narat S; Gandla J; Dogan A; Mehta A
Leuk Lymphoma; 2005 Aug; 46(8):1229-32. PubMed ID: 16085567
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
Hensel M; Ho AD
Am J Hematol; 2003 May; 73(1):37-40. PubMed ID: 12701118
[TBL] [Abstract][Full Text] [Related]
9. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
[TBL] [Abstract][Full Text] [Related]
10. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment.
Fietz T; Rieger K; Schmittel A; Thiel E; Knauf W
Hematol J; 2004; 5(5):451-2. PubMed ID: 15448675
[No Abstract] [Full Text] [Related]
11. Rituximab as treatment for minimal residual disease in hairy cell leukaemia.
Cervetti G; Galimberti S; Andreazzoli F; Fazzi R; Cecconi N; Caracciolo F; Petrini M
Eur J Haematol; 2004 Dec; 73(6):412-7. PubMed ID: 15522063
[TBL] [Abstract][Full Text] [Related]
12. Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia.
Thachil J; Mukherje K; Woodcock B
Br J Haematol; 2006 Oct; 135(2):273-4. PubMed ID: 16965386
[No Abstract] [Full Text] [Related]
13. Rituximab-induced acute thrombocytopenia: a report of two cases.
Otrock ZK; Mahfouz RA; Oghlakian GO; Salem ZM; Bazarbachi A
Haematologica; 2005 Nov; 90 Suppl():ECR23. PubMed ID: 16266914
[TBL] [Abstract][Full Text] [Related]
14. Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases.
Leclerc M; Suarez F; Noël MP; Vekhoff A; Troussard X; Claisse JF; Thieblemont C; Maloisel F; Beguin Y; Tamburini J; Barbe C; Delmer A
Ann Hematol; 2015 Jan; 94(1):89-95. PubMed ID: 25195120
[TBL] [Abstract][Full Text] [Related]
15. Which role for rituximab in hairy cell leukemia? Reflections on six cases.
Malfuson JV; Fagot T; Konopacki J; Souleau B; Cremades S; de Revel T
Acta Haematol; 2010; 123(2):110-6. PubMed ID: 20051682
[TBL] [Abstract][Full Text] [Related]
16. [Complete remission after Rituximab treatment in refractory hairy cell leukemia].
Petruskevicius I; Bukh A; Mertz H; Johnsen HE
Ugeskr Laeger; 2008 Jun; 170(26-32):2350. PubMed ID: 18570771
[TBL] [Abstract][Full Text] [Related]
17. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
[TBL] [Abstract][Full Text] [Related]
18. Advances in the treatment of hairy-cell leukaemia.
Mey U; Strehl J; Gorschlüter M; Ziske C; Glasmacher A; Pralle H; Schmidt-Wolf I
Lancet Oncol; 2003 Feb; 4(2):86-94. PubMed ID: 12573350
[TBL] [Abstract][Full Text] [Related]
19. Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab.
Quach H; Januszewicz H; Westerman D
Haematologica; 2005 Nov; 90 Suppl():ECR26. PubMed ID: 16266917
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Else M; Dearden CE; Catovsky D
Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
